Cataract surgery is done to eliminate blackening of the natural lens from the eye. During the procedure, an intraocular lens is inserted simultaneously. Circumstances under which a person can be diagnosed with cataract is by birth, or because of physical or physical injury. Devices used during the ophthalmology cataract surgery treat the cataract issue and causes no damage to the cornea. Cataract surgery is basically a carefree procedure with successful results. As stated by WHO, in 2010, half of the world suffered from blindness due to cataract, which is around 20 million public. Three types of cataracts namely: Cortical cataracts, Nuclear cataracts, Sub capsular cataracts
Cataract is basically common among the elderly population in the developed countries and moreover is a common ocular infection worldwide. For instance, according to the data enlisted by National Institutes of Health (NIH), worldwide, massive consequences are faced by the public due to cataract which is; over 22 million Americans are infected and that half % of the population will be infected by the age of 80. These terrifying statistics regarding cataract makes it necessary for advancement in technologies for the treatment of cataract to improve the conditions of the patients.
Factors restraining the growth of the market are lack of knowledge about eye disorders, lack of health care insurance and lack of infrastructures for health care.
Segmentation of the market: –
Product type: – Femtosecond laser Equipment, intraocular lens (IOL), Phacoemulsification Equipment and Ophthalmic Viscoelastic Device (OVD). Worldwide, Phacoemulsification is recommended whereas in developing countries like India and China, suture less and manual Small-Incision Cataract Surgery (SICS) is recommended as it’s feasible. Dissimilarity in income levels among rural and urban areas and minimal access to health care facilities, led to increase in the utilization of advanced IOLs and foldable IOLs in emerging countries like India and China. Femtosecond lasers assure cost-effectiveness without any damage to the tissues. These lasers together with optical delivery systems that are computer-controlled has led to accurate openings without any injury to the encircling tissues.; End-users: – Clinics, Ophthalmology centers and Hospitals.;
Geography: – Middle east and Africa, Latin America, North America, Asia Pacific and Europe. Due to increased geriatric population in North America, it dominates the market. As stated by America’s Prevent Blindness, less than 1/5th of the U.S. population, aged 40years and above, are infected by cataract also, around twenty-four million Americans are identified with cataract. In 2015, Novartis healthcare stated that, every year, around four million cataract treatments took place in the U.S. Factors obstructing the growth of the market in the U.S. are slowing economy pose and market dripping. Economic growth in China and India as well as the growing population are the factors anticipated for the growth of Asia Pacific market.
Companies namely, STAAR Surgical Company (U.S.), Essilor International S.A. (France), Carl Zeiss Meditech AG (Germany), Alcon, Inc., Abbott Laboratories (U.S.), and opcon Corporation (Japan), among others are expected to remain active in the expansion of global ophthalmology cataract surgery devices market through 2024.
Request Report Sample@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14126